Candel Therapeutics, Inc.

NASDAQ:CADL

4.98 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -55.177-37.939-18.794-36.124-17.68-8.24
Depreciation & Amortization 0.990.960.7780.2320.0910.043
Deferred Income Tax 00011.5114.6050
Stock Based Compensation 5.3123.0912.3072.9632.1070.4
Change In Working Capital 0.346-0.5250.071-0.8761.7740.513
Accounts Receivables 000000
Inventory 000000
Accounts Payables -0.1850.045-1.2130.6690.2890.013
Other Working Capital 0.531-0.571.284-1.5451.4850.5
Other Non Cash Items 21.5060.169-15.7810.0760.0322.107
Operating Cash Flow -27.023-34.244-31.419-22.218-9.071-5.177
Investing Activities:
Investments In Property Plant And Equipment -0.016-0.457-1.297-1.835-1.476-0.159
Acquisitions Net 0000-39.931-0.846
Purchases Of Investments 0000-0.006-39.107
Sales Maturities Of Investments 000039.9374.371
Other Investing Activites 00.1770039.931-34.736
Investing Cash Flow -0.016-0.28-1.297-1.83538.455-35.741
Financing Activities:
Debt Repayment -9.167019.9100.460
Common Stock Issued 101.75800.06471.3350.0322.501
Common Stock Repurchased 0-0.1210000
Dividends Paid 000000
Other Financing Activities 1.689-0.1210.0640.4650.0344.479
Financing Cash Flow 94.28-0.12119.97471.80.4921.979
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 67.241-34.645-12.74247.74729.874-18.939
Cash At End Of Period 102.9235.67970.32483.06635.3195.445